Why Did the FALCON Clinical Trial End?

Why Did the FALCON Clinical Trial End?

Published on May 23, 2023 | On May 10, the ongoing FALCON clinical trial was terminated early. FALCON is a Phase 3 clinical study evaluating the effectiveness and safety of bardoxolone methyl (an oral investigational drug) in patients with ADPKD. The study aimed for...
Meet the 2023 Kaplan Award Winner

Meet the 2023 Kaplan Award Winner

Published on January 31, 2023 | In 2002, the PKD Foundation and the International Society of Nephrology established the Lillian Jean Kaplan International Prize for Advancement In the Understanding of Polycystic Kidney Disease, also known as the Kaplan Award. Created...
Research Spotlight: Harold Aukema, Ph.D.

Research Spotlight: Harold Aukema, Ph.D.

Published on July 19, 2022 | Harold Aukema, Ph.D., University of Manitoba (Co-Funded by PKD Foundation of Canada)   How did you first get involved in PKD research? Harold Aukema: When I was a graduate student, our lab acquired one of the first models of PKD and I...
Research Spotlight: Laura Onuchic, M.D.

Research Spotlight: Laura Onuchic, M.D.

Published on June 28, 2022 | Laura Onuchic, M.D., Yale School of Medicine   How did you first get involved in PKD research? Laura Onuchic: The fight against PKD has been a part of my life for as long as I can remember. Both my parents are incredible medical...